Indian In Vitro Diagnostics (IVD) Market By Product Type (IVD Equipment and IVD Reagents); Technology Type (Clinical Chemistry, Molecular Diagnostics, Immunoassay, Clinical Microbiology, Coagulation, Hematology, Urinalysis, Blood Gas & Electrolytes, and Others); Application Type (Oncology, Immunology, Infectious Disease, Cardiovascular, Metabolism, Nephrology, and Others); End-users (Hospitals, Laboratories, Point-of-Care, Home Care, Research Institutes, and Others) – Forecast up to 2025

  • April, 2019
  • Domain: Healthcare - Diagnostics
Pages: 78
Tables: 29
Charts: 17
Regions/Countries: 0 / 1
Companies: 12
Enquiry Hours: 10
  • Get Free 10% Customization in this Report

[78 Pages report] This market research report includes a detailed segmentation of the Indian In Vitro Diagnostics market by product type (IVD Equipment and IVD Reagents); by technology type (Clinical Chemistry, Molecular Diagnostics, Immunoassay, Clinical Microbiology, Coagulation, Hematology, Urinalysis, Blood Gas & Electrolytes, and Others); by Application type (Oncology, Immunology, Infectious Disease, Cardiovascular, Metabolism, Nephrology, and Others); by end-users (Hospitals, Laboratories, Point-Of-Care, Home Care, Research Institutes, and Others).

Overview of the Indian In Vitro Diagnostics Market

Infoholic’s market research report predicts that the “Indian In Vitro Diagnostics Market” will grow at a CAGR of ~13.0% during the forecast period 2019–2025. The market is immensely driven by the increase in the number of chronic and lifestyle-related disorders, increasing cancer incidences, growing awareness on the importance of early diagnosis and prevention, and improving access to healthcare facilities and diagnostic set-ups.

Diagnostic tests are frequently performed in public or private laboratories equipped with suitable and expensive instrumentation along with skilled and trained personnel for analysis. The diagnostics market is experiencing quick progress due to advancements in oncology, molecular diagnostics, point-of-care, and novel sectors such as companion diagnostics in both developed and developing economies. The market is driven by an increase in the elderly population, intensification of chronic diseases, pandemic situations in case of infectious diseases, and the growing importance of medical diagnostics.

Indian-IVD-Market-Trends

The majority of the revenue is generated from the leading players in the market with dominating sales from Danaher Corporation, Abbott Laboratories, bioMerieux, F. Hoffmann-La Roche, Siemens, Sysmex Corp., Thermo Fisher Scientific, Transasia Bio-Medicals Ltd., Bio-Rad Laboratories, Ortho Clinical Diagnostic, QIAGEN N.V., and Shanghai Fosun Pharmaceutical Co. Ltd.

Indian In Vitro Diagnostics Market Segmentation By Product Type:


  • IVD Reagents

  • IVD Equipment



  •  
  •  


IVD reagents holds the major share in the Indian IVD market followed by IVD equipment in 2018. Transasia Bio-Medicals is the leader of India’s IVD market with over 45,000 installation bases across India.

Indian In Vitro Diagnostics Market Segmentation By Technology Type:

 


  • Immunoassay

  • Biochemistry

  • Hematology

  • Microbiology

  • Blood Gas and Diagnostics

  • Molecular Diagnostics

  • Urinalysis

  • Coagulation



  •  
  •  


Biochemistry holds a significant share in the Indian IVD market in 2018. It is to be noted that TB culture accounts for 15–20% of the overall molecular diagnostic nowadays. The increasing adoption of point-of-care testing is also driving the market locally in India.

Indian In Vitro Diagnostics Market Segmentation By Application Type:

 

 


  • Oncology

  • Infectious Disease

  • Diabetes

  • Cardiology

  • Nephrology

  • Autoimmune Disease

  • Others



  •  
  •  


The industry has reached new heights with significant technological advances and greater performance technologies. Advanced, state-of-the-art techniques are used to comprehend disease prognosis and thus strengthen the standard of sophistication of the industry respondents.

Indian In Vitro Diagnostics Market Segmentation By End-users:

 

 


  • Hospitals

  • Laboratories

  • Home Care

  • Academic and Research Institute

  • Others



  •  
  •  


Hospitals hold major share in the Indian IVD market. Hospitals and reference laboratories are expecting the development of products that will provide reliable results at great speed to reduce wrong diagnosis and treatment time.

Indian In Vitro Diagnostics Market Research Competitive Analysis – There has been a paradigm shift arising in the implementation of technology and automation. The need for precise and rapid results has resulted in the implementation of high-end products for in-depth evaluation. The Indian government supports Public–Private Partnerships (PPPs) and other innovative schemes to enhance Indian IVD advancement. Foreign Direct Investment (FDI) and domestic study have been encouraged by the government to support the industry. The number of players in the segment offering quality products and after-sales services has risen.

Key Vendors:

 

 


  • Danaher Corporation

  • Abbott Laboratories

  • bioMerieux

  • Hoffmann-La Roche

  • Siemens

  • Transasia Bio-Medicals Ltd.



  •  
  •  


Key Competitive Facts

 

 


  • The future growth of the Indian In Vitro Diagnostic market will be driven by Tier-II and Tier-III cities and that is where the price of the products and testing consumables will matter the most.

  • Hospitals and reference laboratories are expecting the development of products that will provide reliable results at great speed to reduce wrong diagnosis and treatment time.



  •  
  •  


Benefits The report provides complete details about the sub-segments of the Indian In Vitro Diagnostics market. Through this report, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward the disease management in the upcoming years along with details of the existing pure-play companies and new players entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals and to analyze before investing or expanding the business in this market.

Key Takeaways:

 

 


  • Understanding the potential market opportunity with precise market size and forecast data.

  • A detailed market analysis focusing on the growth of the Indian IVD

  • Factors influencing the growth of the Indian IVD

  • In-depth competitive analysis of dominant and pure-play vendors.

  • Prediction analysis of the Indian IVD market.

  • Key insights related to major segments of the Indian IVD

  • Latest market trend analysis impacting the buying behavior of the consumers.



  •  
  •  


 Key Stakeholders

Indian-IVD-Stakeholders

 

1            Industry Outlook 

1.1          IVD Industry Structure and Overview

1.2          Major Market Factors and Growth Drivers

1.3          Total Addressable Market

1.4          Industry Trends

2              Report Outline 

2.1          Report Scope

2.2          Report Summary

2.3          Research Methodology

2.4          Report Assumptions

3              Market Snapshot  

3.1          Market Definition – Infoholic Research

3.2          Advantages of IVD

3.3          Importance of IVD

3.4          Segmented Addressable Market

3.5          Trends in the Indian In Vitro Diagnostics Market

3.6          Related Market

4              Market Outlook

4.1          Market Segmentation

4.2          PESTLE Analysis

4.3          Porter 5 (Five) Forces

5              Market Characteristics 

5.1          DRO – Market Dynamics

5.1.1      Drivers

5.1.1.1   Economic growth, increasing population, urbanization, and rising healthcare expenditure per capita

5.1.1.2   Sedentary lifestyle, increasing prevalence of smoking and alcohol consumption resulting in incidence of lifestyle-related chronic disorders, cancer, and infectious diseases

5.1.1.3   Growing penetration of IVD testing in tier-II and III cities

5.1.1.4   Growing market of biomarker-based and genetic testing in India

5.1.2      Opportunities

5.1.2.1   Point-of-care testing, near patient testing, and home-based testing products and services (direct-to-patient testing services)

5.1.2.2   Adoption of fully automated systems in India and increasing number of phase-III clinical trials in India

5.1.3      Restraints

5.1.3.1   High costs of testing cancer, genetic disorders, and other disease

5.1.3.2   Tightening regulatory requirements but lack of reimbursement policies

5.1.4      DRO – Impact Analysis

5.1.5      Key Stakeholders

6              IVD Market Segments: Reagents and Equipment

7              Technology Types: Market Size and Analysis

7.1          Overview

7.2          Immunoassay

7.3          Biochemistry

7.4          Hematology

7.5          Microbiology

7.6          Blood Gas & Electrolytes

7.7          Molecular Diagnostics

7.8          Urinalysis

7.9          Coagulation

8              Applications: Market Size and Analysis   

8.1          Overview

8.2          Oncology

8.3          Infectious Disease

8.4          Diabetes

8.5          Cardiology

8.6          Nephrology

8.7          Autoimmune Disease

8.8          Others

9              End-users: Market Size and Analysis

9.1          Overview

9.2          Hospitals

9.3          Laboratories

9.4          Home Care

9.5          Academic and Research Institutes

9.6          Others

10           Competitive Landscape

10.1        Overview

11           Vendors Profile

11.1        Abbott Laboratories

11.2        Danaher Corporation

11.3        bioMerieux

11.4        F. Hoffmann La Roche

11.5        Siemens

11.6        Transasia Bio-Medical Ltd

12           Companies to Watch for   

12.1        Sysmex Corporation

12.2        Thermo Fisher Scientific

12.3        Bio-Rad Laboratories

12.4        Ortho Clinical Diagnostic

12.5        QIAGEN N.V.

12.6        Shanghai Fosun Pharmaceutical Co. Ltd.

Annexure 

Abbreviations

Research Framework

Infoholic research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:

  • Data Collation (Primary & Secondary)
  • In-house Estimation (Based on proprietary data bases and Models)
  • Market Triangulation
  • Forecasting

Market related information is congregated from both primary and secondary sources.

Primary sources

involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.

Secondary sources

include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.

Interested in this report?
Get your FREE sample now!

Select User License

$

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer 10% worth of FREE customization at the time of purchase

Related Reports